University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

CGM/Clarity Use, Glycemic Control and Clinical Outcomes

Not Applicable

Withdrawn

Conditions: Hyperglycemia
Diabetes Mellitus
Hypoglycemia

Interventions: Other: Point of Care (POC) blood glucose
Device: Continuous glucose Monitoring Devices and Clarity Software

First Posted Date: 2019-02-01

Last Posted Date: 2024-11-26

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT03827434

Locations: 🇺🇸
Baltimore VA Medical Center, Baltimore, Maryland, United States

Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication

Phase 4

Completed

Conditions: Hepatitis C
Hiv
Cardiovascular Diseases

Interventions: Drug: Elbasvir / Grazoprevir Oral Tablet [Zepatier]
Procedure: Cardiac MRI

First Posted Date: 2019-01-31

Last Posted Date: 2023-05-22

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 87

Registration Number: NCT03823911

Locations: 🇺🇸
Unity Parkside Health Center, Washington, District of Columbia, United States
🇺🇸
Institute of Human Virology, CRU, Baltimore, Maryland, United States

Preop Digifab in CABG to Reduce Ouabain Levels and Prevent AKI

Phase 4

Completed

Conditions: Acute Kidney Injury

Interventions: Drug: Digoxin Antibodies Fab Fragments
Other: Placebo

First Posted Date: 2019-01-18

Last Posted Date: 2024-05-01

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 250

Registration Number: NCT03810417

Locations: 🇺🇸
St Josephs Medical Center, Baltimore, Maryland, United States
🇺🇸
University of Maryland, Baltimore, Maryland, United States

Obesity Study to Assess Induction of Labor

Not Applicable

Withdrawn

Conditions: Induction of Labor Affected Fetus / Newborn

Interventions: Drug: Misoprostol

First Posted Date: 2019-01-08

Last Posted Date: 2022-03-22

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT03796416

B/F/TAF Switch Study for HIV-HBV Coinfection

Phase 4

Completed

Conditions: Hepatitis B
HIV-1-infection

Interventions: Drug: B/F/TAF

First Posted Date: 2019-01-08

Last Posted Date: 2023-11-03

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 28

Registration Number: NCT03797014

Locations: 🇺🇸
Newlands Health, Philadelphia, Pennsylvania, United States
🇺🇸
Institute of Human Virology Clinical Research Unit, Baltimore, Maryland, United States

KCNQ1 Cascade Screening

Not Applicable

Terminated

Conditions: Long QT Syndrome

Interventions: Genetic: Simplified Cascade Screening

First Posted Date: 2018-12-21

Last Posted Date: 2023-06-27

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 131

Registration Number: NCT03783975

Locations: 🇺🇸
University of Maryland Amish Research Clinic, Lancaster, Pennsylvania, United States

Service Dog Training Program for Military Veterans With PTSD

Not Applicable

Completed

Conditions: Post Traumatic Stress Disorder

Interventions: Other: Dog Training Education
Behavioral: Service Dog Training Program

First Posted Date: 2018-12-17

Last Posted Date: 2024-07-26

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 60

Registration Number: NCT03777020

Locations: 🇺🇸
Warrior Canine Connections, Boyds, Maryland, United States

Dental Carotid Cognitive Study

Not Applicable

Terminated

Conditions: Carotid Stenosis
Periodontitis
Mild Cognitive Impairment

Interventions: Procedure: Standard Treatment
Procedure: Intensive Treatment

First Posted Date: 2018-11-28

Last Posted Date: 2021-07-23

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 26

Registration Number: NCT03755362

Locations: 🇺🇸
University of Maryland - Administrative Center, Baltimore, Maryland, United States

Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing

Phase 4

Terminated

Conditions: Fluid Overload
Heart Failure Acute

Interventions: Drug: Metolazone 60 minutes prior to furosemide
Drug: Metolazone concurrently with furosemide

First Posted Date: 2018-11-19

Last Posted Date: 2021-10-22

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 3

Registration Number: NCT03746002

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

B'More for a Peaceful Motherhood Hypertension Control Study

Not Applicable

Terminated

Conditions: Hypertension

Interventions: Behavioral: High blood pressure management education
Behavioral: Home blood pressure measurement

First Posted Date: 2018-11-15

Last Posted Date: 2021-04-14

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 23

Registration Number: NCT03741608

Locations: 🇺🇸
Leonard E. Hicks Community Center, Baltimore, Maryland, United States
🇺🇸
Furman L. Templeton Preparatory Academy, Baltimore, Maryland, United States
🇺🇸
Union Baptist Harvey Johnson Head Start Program, Baltimore, Maryland, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy